Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi


  • Gail A. BishopEmail author
  • Bruce S. Hostager
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_148


 Bp50;  CDW40;  MGC9013;  p50;  TNFRSF5

Historical Background

CD40, a 50kDa transmembrane member of the tumor-necrosis factor (TNF) receptor (TNFR) superfamily of molecules, plays a key role in adaptive immune responses. This includes contact-mediated signals to B cells from activated T lymphocytes, as well as costimulatory interactions between T cells and other antigen-presenting cells (APC), such as dendritic cells (DC) and macrophages. CD40-mediated interactions between B and T cells make important contributions to the development of an optimal humoral memory response (Bishop 2009).

CD40 lacks intrinsic enzymatic activity and therefore depends on cytoplasmic (CY) adaptor molecules referred to as TNFR-associated factors (TRAFs) for delivery of signals to the cytoplasm. CD40 engagement on B cells stimulates the binding of TRAFs to the CD40 CY domain. This in turn stimulates kinase activity and gene expression pathways that lead to a variety of responses, including B cell...

This is a preview of subscription content, log in to check access.


  1. Arcipowski KM, Bishop GA. Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1. PLoS One. 2012;7:e42478.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Baccam M, Woo S, Vinson C, Bishop GA. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: Involvement of NF-κB, AP-1, and C/EBP. J Immunol. 2003;170:3099–108.PubMedCrossRefGoogle Scholar
  3. Bishop GA. The many faces of CD40: Multiple roles in normal immunity and disease. Semin Immunol. 2009;21:255–312.PubMedCrossRefGoogle Scholar
  4. Bishop GA. The multifaceted roles of TRAFs in the regulation of B cell function. Nat Rev Immunol. 2004;4:775–86.PubMedCrossRefGoogle Scholar
  5. Bishop GA. The power of mAbs as agents of discovery: CD40 revealed as a B lymphocyte costimulator. J Immunol. 2012;188:4127–9.  https://doi.org/10.4049/jimmunol.1200775.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bishop GA, Hostager BS. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003;14:297–309.PubMedCrossRefGoogle Scholar
  7. Bishop GA, Hostager BS. Molecular mechanisms of CD40 signaling. Arch Immun Ther Exper. 2001a;49:129–37.Google Scholar
  8. Bishop GA, Hostager BS. Signaling by CD40 and its mimics in B cell activation. Immunol Res. 2001b;24:97–109.PubMedCrossRefGoogle Scholar
  9. Bishop GA, Hostager BS, Brown KD. Mechanisms of TRAF regulation in B lymphocytes. J Leukoc Biol. 2002;72:19–23.PubMedPubMedCentralGoogle Scholar
  10. Bishop GA, Moore CR, Xie P, Stunz LL, Kraus ZJ. TRAF proteins in CD40 signaling. Adv Exp Biol Med. 2007;597:131–51.CrossRefGoogle Scholar
  11. Fang D-F, He K, Wang N, Sang Z, Qiu X, Xu G, et al. NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activation. Nature Comm. 2014;5:1–11.  https://doi.org/10.1038/ncomms5513.CrossRefGoogle Scholar
  12. Graham JP, Arcipowski KM, Bishop GA. Differential B lymphocyte regulation by CD40 and its viral mimic, LMP1. Immunol Rev. 2010;237:226–48.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Häcker H, Tseng P-H, Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 2011;11:457–68.PubMedCrossRefGoogle Scholar
  14. Haxhinasto SA, Hostager BS, Bishop GA. Cutting Edge: Molecular mechanisms of synergy between CD40 and the BCR: Role for TRAF2 in receptor interaction. J Immunol. 2002;169:1145–9.PubMedCrossRefGoogle Scholar
  15. Hildebrand JM, Yi Z, Buchta CM, Poovassery JS, Stunz LL, Bishop GA. Roles of TRAF3 and TRAF5 in immune cell function. Immunol Rev. 2011;244:55–74.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Hostager BS. Roles of TRAF6 in CD40 signaling. Immunol Res. 2007;39:105–14.PubMedCrossRefGoogle Scholar
  17. Hostager BS, Bishop GA. CD40-mediated activation of the NF-κB2 pathway. Front Immunol 2013;4:Article 376, 1–4.Google Scholar
  18. Hostager BS, Kashiwada M, Colgan J, Rothman PB. HOIP is essential for CD40 signaling. PLoS One. 2011;6:e23061.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Hsing Y, Bishop GA. Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol. 1999;162:2804–11.PubMedPubMedCentralGoogle Scholar
  20. Karin M, Gallagher E. TNFR signaling: ubiquitin-conjugated traffic signals control stop-and-go for MAPK signaling complexes. Immunol Rev. 2009;228:225–40.PubMedCrossRefGoogle Scholar
  21. Lin WW, Hostager BS, Bishop GA. TRAF3, ubiquitination, and B lymphocyte regulation. Immunol Rev. 2015;266:46–55.  https://doi.org/10.1111/lmr.12299.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Miliara S, Gkouskou KK, Sharp TV, Eliopoulos AG. SUMOylation is required for optimal TRAF3 signaling capacity. PLoS One. 2013;8:e80470.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Mukundan L, Bishop GA, Head KZ, Zhang L, Wahl LM, Suttles J. TRAF6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. J Immunol. 2005;174:1081–90.PubMedCrossRefGoogle Scholar
  24. Peters AL, Stunz LL, Bishop GA. CD40 and autoimmunity: the dark side of a great activator. Semin Immunol. 2009;21:293–300.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Rowland SR, Tremblay ML, Ellison JM, Stunz LL, Bishop GA, Hostager BS. A novel mechanism for TRAF6-dependent CD40 signaling. J Immunol. 2007;179:4645–53.PubMedCrossRefGoogle Scholar
  26. Sasaki Y, Sano S, Nakahara M, Murata S, Kometani K, Aiba Y, et al. Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J. 2013;32:2463–76.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci. 2001;58:4–43.PubMedCrossRefGoogle Scholar
  28. Uckun FM, Schieven GL, Dibirdik I, Chandan-Langlie M, Tuel-Ahlgren L, Ledbetter JA. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified ser/thr-specific protein kinases by the pan-BCR CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J Biol Chem. 1991;266:17478–85.PubMedPubMedCentralGoogle Scholar
  29. Yi Z, Bishop GA. Regulatory role of CD40 in obesity-induced insulin resistance. Adipocyte. 2014;4.  https://doi.org/10.4161/adip.32214.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Yi Z, Lin WW, Stunz LL, Bishop GA. Roles for TRAF3 in lymphocyte functions. Cytokine Growth Factor Rev. 2014;25:146–56.CrossRefGoogle Scholar
  31. Zarnegar B, He JQ, Oganesyan G, Hoffmann A, Baltimore D, Cheng G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways. Proc Natl Acad Sci USA. 2004;101:8108–13.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Departments of Microbiology and Internal MedicineThe University of Iowa and VAMCIowa CityUSA
  2. 2.Department of MicrobiologyUniversity of IowaIowa CityUSA